Results 211 to 220 of about 26,546 (243)

[Pharmacological treatment resistant schizophrenia].

Actas espanolas de psiquiatria, 2006
In the clinical practice, there are three different terms to designate schizophrenic patients who do not improve with antipsychotic medication: treatment-resistant, treatment-refractory and non-respondent patients. Treatment resistance is neither a synonym of chronicity nor of severity nor seriousness.
S, Cervera Enguix, A, Seva Fernández
openaire   +1 more source

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

[Management of treatment resistance-Treatment-resistant schizophrenia].

Der Nervenarzt
Despite a very high prevalence and substantial impairments among affected individuals, treatment-resistant schizophrenia (TRS) has not been sufficiently researched in clinical research in the field of psychiatric disorders and the pathophysiology is still poorly understood.
Elias, Wagner, Stefan, Borgwardt, Alkomiet, Hasan   +2 more
openaire   +1 more source

Clozapine for Treatment-Resistant Schizophrenia

American Journal of Therapeutics, 2016
Peter, Manu, Eugene, Grudnikoff
openaire   +2 more sources

Treatment-resistant schizophrenia

2012
William Spaulding, Robert Johnson, Jeffrey Nolting, Amanda Messman   +3 more
openaire   +2 more sources

Treatment-Resistant Schizophrenia

2010
Marc Turiault, Caroline Cohen, Guy Griebel, David E. Nichols, Britta Hahn, Gary Remington, Ronald F. Mucha, Emma Childs, Darren R. Christensen, Warren K. Bickel, Darren R. Christensen, Warren K. Bickel, Andrea Bari, Rosa M. M. de Almeida, Klaus A. Miczek, Sheldon Preskorn, Megan M. Dahmen, Janka Lincoln, Emma Childs, Tomasz Schneider, Pierre Baumann, Britta Hahn, W. Wolfgang Fleischhacker, W. Wolfgang Fleischhacker, W. Wolfgang Fleischhacker, Trevor W. Robbins, Emma Childs, Lawrence Scahill, Lawrence Scahill, Lawrence Scahill, Lawrence Scahill, Ben J. Harrison, Christos Pantelis, Warren H. Meck, Catalin V. Buhusi, Catalin V. Buhusi, Warren H. Meck, Warren H. Meck, Catalin V. Buhusi, Seiya Miyamoto, Harriet de Wit, David C. S. Roberts, Robert L. Balster, Robert Kessler, Ronald L. Cowan, Johannes Mosbacher, Emma Childs, Sara Tomlinson, Glen B. Baker, Sara Tomlinson, Glen B. Baker, Mark Slifstein, Suzanne H. Mitchell, Harriet de Wit, Tara L. White, Richard A. Depue, Martine Cador, Lawrence H. Price, Jean-Michel Scherrmann, Etienne Sibille, Nicole Edgar, Christof Baltes, Thomas Mueggler, Markus Rudin, Thomas Steckler, Josee E. Leysen, Stephen M. Stahl, Meghan M. Grady, Klaus A. Miczek, Joseph Zohar, Klaus A. Miczek, Linda Lundström, Silvia Gatti McArthur, Will Spooren, Gary Remington, Ashwini Padhi, Naomi A. Fineberg, Josee E. Leysen, Emma Childs, Robert L. Balster, Subhash C. Pandey, Michael H. Bloch, Sidney H. Kennedy, Sakina J. Rizvi, Clemens Kirschbaum, W. Wolfgang Fleischhacker, Harriet de Wit, Theodora Duka, David S. Middlemas, David B. Bylund, A. Claudio Cuello, David E. Nichols, Lawrence H. Price, Simon N. Young, Peter Verhaert, Per Svenningsson, Per E. Andrén, Tiffany Thomas, Robert L. Findling   +98 more
openaire   +2 more sources

TREATMENT-RESISTANT SCHIZOPHRENIA

The Lancet, 1989
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

Ca-A Cancer Journal for Clinicians, 2020
Aaron J Grossberg, William L Hwang, Anirban Maitra   +2 more
exaly  

Oral complications of cancer and cancer therapy

Ca-A Cancer Journal for Clinicians, 2012
Joel B Epstein, Rene-Jean Bensadoun, Andrei Barasch   +2 more
exaly